Johnson & Johnson Starts a New Era in Hip and Knee Revision Surgery with KINCISE 2

Johnson & Johnson MedTech has launched the KINCISE™ 2 Surgical Automated System, marking a significant advance in orthopedic surgery. This next-generation power tool is now the first and only automated surgical impactor approved for both primary and revision hip and revision knee procedures, including the complex task of acetabular cup extraction.

Now available in the U.S., the KINCISE 2 system addresses one of the most overlooked challenges in modern surgery: surgeon fatigue. Orthopedic procedures often require repeated, high-force mallet strikes — a major contributor to chronic musculoskeletal pain among surgeons. In fact, 97% of surgeons report work-related pain, particularly in the lower back, hands, and neck.

KINCISE 2 is designed to tackle that issue head-on. Unlike manual mallets, this automated system offers consistent, high-precision impact, helping reduce physical strain and improve workflow in the operating room. It also features new enhancements, including increased reverse energy and “push to lock” adaptors that support a more fluid surgical experience. For hip revisions, the addition of Acetabular Cup Extraction expands its utility, giving surgeons a tool to remove well-fixed components without traditional manual effort.

“When I think about what the KINCISE™ 2 System means for the future of orthopedic care, it’s simple: it helps surgeons stay at their best, longer,” said Dr. Vasilios Mathews||, M.D., Texas Orthopedic Hospital. “This system is designed to reduce strain and support surgical precision, which means we can focus more fully on the patient in front of us. That’s the true value – technology that not only improves surgical experience but helps us deliver better outcomes for every patient we treat.”

Johnson & Johnson says KINCISE 2 is part of a broader strategy to develop smarter, adaptive med-tech solutions. With the rise in joint replacements among younger patients, revision surgeries are becoming more common, and systems like KINCISE are critical for improving care quality while managing procedural complexity.

The company also points out that automated impactors like KINCISE have been shown to reduce overall surgical time and provide more consistent results, helping to standardize care across institutions.

“The KINCISE™ 2 System exemplifies the needs-based innovation we’re bringing to Orthopedics this year,” said Aldo Denti, Company Group Chairman at Johnson & Johnson MedTech.

With KINCISE 2, Johnson & Johnson is not just upgrading surgical tools — it’s redefining the surgical experience, making procedures safer, faster, and more ergonomically sound for the next generation of orthopedic surgeons.